Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Marco Ruiz is a Medical Oncologist in Hematologic Cancers specializing in leukemia, lymphoma, myelodysplastic syndrome, myelofibrosis, HIV related malignancies, stem cell transplants, geriatric oncology, and palliative medicine at the Miami Cancer Institute in Miami, Florida.  He is also an experienced bone marrow transplant specialist and is active in cancer research. Growing up the son of a nurse, Dr. Ruiz knew at a young age that he wanted to pursue a career in medicine. But it was his father’s battle with cancer that sparked a passion for helping patients with the disease.

Spanish Blood Cancer Library - What is the chimeric T cell receptors treatment against tumoral antigens (CAR-T)? and how does it work?
¿Cuál es la terapia de receptores de linfocitos T quiméricos contra antígenos tumorales (CAR-T)? y ¿Cómo funciona?
Author
Marco A. Ruiz, MD, GRACE Faculty
Image
GRACE sat down with Dr. Marco Ruiz to discuss information regarding the chimeric T cell receptors treatment against tumoral antigens (CAR-T) and how it works (¿Cuál es la terapia de receptores de linfocitos T quiméricos contra antígenos tumorales (CAR-T)? y ¿Cómo funciona ?).  
 
Stay tuned for more on our continuing video series with our Spanish speaking faculty on updates in blood cancer treatments, and Chronic Lymphocytic Leukemia & Non-Hodgkin Lymphoma, (Leucemia crónica linfocítica y linfoma no Hodgkin).

 

We would like to thank the following company for their support of this program:

 


 

Video Language

Next Previous link

Previous PostNext Post

Related Content

Image
East Asian Lung Cancer VL 2025
Video
2025 동아시아 폐암 이미지 라이브러리의 일환으로 서정민 박사(분당서울대학교병원)가 절제 가능한 비소세포 폐암의 수술 주변 관리에 대해 논의합니다.  2025 동아시아 폐암 영상 라이브러리의 일환으로, 김진용 박사(삼성메디컬센터)는 EGFR 돌연변이가 있는 비소세포 폐암 환자를 위한 표적 치료에 대해 논의합니다.
Article
As part of the 2025 Blood Cancer Video Library, where oncologists discuss the most emerging treatment options and information in blood cancer, Dr. Shaji Kumar (Mayo Clinic) discusses optimal strategies for the treatment of newly diagnosed multiple myeloma (MM).